Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

BACKGROUND: Juvenile idiopathic arthritis (JIA)-associated uveitis is a chronic paediatric ocular inflammatory condition that can result in visual impairment. Adalimumab, a tumour necrosis factor (TNF)-alpha inhibitor, effectively controls joint and eye inflammation; however, its long-term use may i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Trials
Hlavní autoři: Acharya, Nisha R., Ebert, Caleb D., Kelly, Nicole K., Porco, Travis C., Ramanan, Athimalaipet V., Arnold, Benjamin F.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590716/
https://ncbi.nlm.nih.gov/pubmed/33109240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04796-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky